233 related articles for article (PubMed ID: 23706327)
21. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of ischemic stroke patients with concurrent intracranial and extracranial stenoses and ischemic heart disease.
Man BL; Fu YP; Chan YY; Lam W; Hui CF; Leung WH; Mok V; Wong KS
Cerebrovasc Dis; 2010 Feb; 29(3):236-41. PubMed ID: 20029196
[TBL] [Abstract][Full Text] [Related]
23. Is the long-term prognosis of transient ischemic attack or minor ischemic stroke affected by the occurrence of nonfocal symptoms?
Compter A; van der Worp HB; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Stroke; 2014 May; 45(5):1318-23. PubMed ID: 24652304
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of clinical history and electrocardiogram in patients with transient ischemic attack or minor ischemic stroke for subsequent cardiac and cerebral ischemic events. The Dutch TIA Trial Study Group.
Pop GA; Koudstaal PJ; Meeder HJ; Algra A; van Latum JC; van Gijn J
Arch Neurol; 1994 Apr; 51(4):333-41. PubMed ID: 8155010
[TBL] [Abstract][Full Text] [Related]
25. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
[TBL] [Abstract][Full Text] [Related]
26. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis.
Touzé E; Varenne O; Chatellier G; Peyrard S; Rothwell PM; Mas JL
Stroke; 2005 Dec; 36(12):2748-55. PubMed ID: 16254218
[TBL] [Abstract][Full Text] [Related]
27. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study.
Vazir A; Claggett B; Cheng S; Skali H; Shah A; Agulair D; Ballantyne CM; Vardeny O; Solomon SD
JAMA Cardiol; 2018 Mar; 3(3):200-206. PubMed ID: 29365021
[TBL] [Abstract][Full Text] [Related]
28. Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
Xu L; Chen Y; Chen S; Wang G; Fu Y; Cai J; Yang X; Wu S; Miao C; Hong J
Int J Cardiol; 2024 Apr; 400():131811. PubMed ID: 38278489
[TBL] [Abstract][Full Text] [Related]
29. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
[TBL] [Abstract][Full Text] [Related]
30. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group.
Dippel DW; Koudstaal PJ
Stroke; 1997 Apr; 28(4):774-6. PubMed ID: 9099195
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
O'Connor CM; Gattis WA; Hellkamp AS; Langer A; Larsen RL; Harrington RA; Berkowitz SD; O'Gara PT; Kopecky SL; Gheorghiade M; Daly R; Califf RM; Fuster V
Am J Cardiol; 2001 Sep; 88(5):541-6. PubMed ID: 11524065
[TBL] [Abstract][Full Text] [Related]
32. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
33. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
Demers C; McMurray JJ; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S;
JAMA; 2005 Oct; 294(14):1794-8. PubMed ID: 16219883
[TBL] [Abstract][Full Text] [Related]
34. Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
Verma S; Poulter NR; Bhatt DL; Bain SC; Buse JB; Leiter LA; Nauck MA; Pratley RE; Zinman B; Ørsted DD; Monk Fries T; Rasmussen S; Marso SP
Circulation; 2018 Dec; 138(25):2884-2894. PubMed ID: 30566004
[TBL] [Abstract][Full Text] [Related]
35. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
[TBL] [Abstract][Full Text] [Related]
36. Vasectomy and subsequent cardiovascular disease in US physicians.
Manson JE; Ridker PM; Spelsberg A; Ajani U; Lotufo PA; Hennekens CH
Contraception; 1999 Mar; 59(3):181-6. PubMed ID: 10382081
[TBL] [Abstract][Full Text] [Related]
37. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
[TBL] [Abstract][Full Text] [Related]
38. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.
Waters DD; Schwartz GG; Olsson AG; Zeiher A; Oliver MF; Ganz P; Ezekowitz M; Chaitman BR; Leslie SJ; Stern T;
Circulation; 2002 Sep; 106(13):1690-5. PubMed ID: 12270864
[TBL] [Abstract][Full Text] [Related]
39. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
[TBL] [Abstract][Full Text] [Related]
40. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
